Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% Market Cap is $9.98 Mil as of Jul. 25, 2026. The stock has 5 warning signs investors should review. Among 2,045 Consumer Packaged Goods companies, PURE Bioscience ranks worse than 86.31% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PURE Bioscience's share price for the quarter that ended in Apr. 2026 was $0.0691. PURE Bioscience's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 130.02 Mil. Therefore, PURE Bioscience's market cap for the quarter that ended in Apr. 2026 was $8.98 Mil.
PURE Bioscience's quarterly market cap
declined
from Oct. 2025 ($7.83 Mil) to Jan. 2026 ($5.20 Mil) but then
increased
from Jan. 2026 ($5.20 Mil) to Apr. 2026 ($8.98 Mil).
PURE Bioscience's annual market cap
declined
from Jul. 2023 ($9.51 Mil) to Jul. 2024 ($8.93 Mil) but then
increased
from Jul. 2024 ($8.93 Mil) to Jul. 2025 ($10.05 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PURE Bioscience's Enterprise Value for Today is $15.49 Mil.
PURE Bioscience (OTCPK:PURE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PURE Bioscience Market Cap Related Terms
PURE Bioscience Market Cap Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, PURE Bioscience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's Market Cap distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PURE Bioscience's Market Cap for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience (PURE) has a Market Cap of $9.98 Mil as of Jul. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #1765 out of 2045 companies in the Consumer Packaged Goods industry, placing it in the top 86.3%.
Is PURE Bioscience's Market Cap too high?
PURE Bioscience's current Market Cap is $9.98 Mil. The Consumer Packaged Goods industry median Market Cap is 102.14. PURE Bioscience's value of $9.98 Mil is 90.2% below this industry median. Based on the distribution chart, PURE Bioscience ranks #1765 out of 2045 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PURE Bioscience's Market Cap compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #1765 out of 2045 companies for Market Cap. This places PURE Bioscience in the lower half of its industry. The industry median Market Cap is 102.14. PURE Bioscience's value of $9.98 Mil is 90.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 102.14, based on 2,045 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current Market Cap of $9.98 Mil is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 102.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current Market Cap is $9.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current Market Cap is $9.98 Mil and 90.2% below the Consumer Packaged Goods industry median of 102.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PURE Bioscience (PURE), the current Market Cap is $9.98 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
